Study on Gynecological Rare Cancers

Prospective, Multicenter, Observational Study on Rare Gynecological Cancers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05733806

Acronym

MITO9B

Enrollment

500

Registered

2023-02-17

Start date

2019-10-14

Completion date

2030-02-01

Last updated

2023-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Cancer

Keywords

rare cancers, gynecologic malignancies

Brief summary

This is a prospective, observational, multicenter study on gynecological rare tumors.

Detailed description

This is a prospective registry aimed to better understand prognosis, clinical and pathological features, management of this rare cancer conditions for improving standard of care.

Interventions

OTHERchemotherapy, surgery

this is an observational prospective study, therefore no intervention is planned. Patients perform medical and surgical treatment as per standard of case.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* rare gynecological malignancies * written informed consent * patient fit for follow-up

Exclusion criteria

-written informed consent not provided

Design outcomes

Primary

Measure	Time frame	Description
Prevalence of gynecologic rare malignancies	5 years	To describe the prevalence of gynecologic rare tumors

Countries

Italy

Contacts

Primary ContactFrancesco Perrone, MD

f.perrone@istitutotumori.na.it0039 081 1777 0276

Backup ContactGiorgia Mangili, MD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026